Cherish Sunshine International Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Cherish Sunshine International.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
IT earnings growth | 13.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Investors Still Aren't Entirely Convinced By Cherish Sunshine International Limited's (HKG:1094) Revenues Despite 167% Price Jump
Aug 30Cherish Sunshine International Limited (HKG:1094) Might Not Be As Mispriced As It Looks After Plunging 30%
Jul 16Many Still Looking Away From Cherish Sunshine International Limited (HKG:1094)
May 22Market Cool On Cherish Sunshine International Limited's (HKG:1094) Revenues Pushing Shares 33% Lower
Feb 02Health Check: How Prudently Does China Public Procurement (HKG:1094) Use Debt?
Sep 07Estimating The Fair Value Of China Public Procurement Limited (HKG:1094)
May 24Is China Public Procurement (HKG:1094) Using Too Much Debt?
Apr 01In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cherish Sunshine International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2024 | 782 | 1 | 12 | 13 | N/A |
12/31/2023 | 594 | 14 | -69 | -66 | N/A |
9/30/2023 | 405 | 28 | -150 | -145 | N/A |
6/30/2023 | 339 | 21 | -186 | -181 | N/A |
3/31/2023 | 272 | 13 | -222 | -217 | N/A |
3/31/2022 | 112 | -26 | -21 | -20 | N/A |
12/31/2021 | 119 | -22 | -4 | -4 | N/A |
9/30/2021 | 110 | -8 | -2 | -1 | N/A |
6/30/2021 | 100 | 5 | 1 | 1 | N/A |
3/31/2021 | 97 | 3 | 1 | 2 | N/A |
12/31/2020 | 94 | 2 | 1 | 2 | N/A |
9/30/2020 | 85 | -5 | 1 | 2 | N/A |
6/30/2020 | 76 | -12 | 2 | 3 | N/A |
3/31/2020 | 75 | -13 | -7 | -5 | N/A |
12/31/2019 | 73 | -14 | -15 | -13 | N/A |
9/30/2019 | 70 | -16 | -21 | -21 | N/A |
6/30/2019 | 67 | -19 | -28 | -28 | N/A |
3/31/2019 | 68 | -22 | -24 | -24 | N/A |
12/31/2018 | 68 | -24 | -20 | -19 | N/A |
9/30/2018 | 69 | -20 | -23 | -23 | N/A |
6/30/2018 | 69 | -16 | -27 | -27 | N/A |
3/31/2018 | 67 | -96 | -27 | -27 | N/A |
12/31/2017 | 65 | -176 | N/A | -27 | N/A |
9/30/2017 | 57 | -263 | N/A | N/A | N/A |
6/30/2017 | 50 | -350 | N/A | -34 | N/A |
3/31/2017 | 51 | -279 | N/A | -42 | N/A |
12/31/2016 | 51 | -208 | N/A | -49 | N/A |
9/30/2016 | 385 | -638 | N/A | N/A | N/A |
6/30/2016 | 735 | -1,057 | N/A | -107 | N/A |
3/31/2016 | 1,626 | -1,062 | N/A | -122 | N/A |
12/31/2015 | 2,516 | -1,068 | N/A | -136 | N/A |
9/30/2015 | 2,762 | -852 | N/A | -157 | N/A |
6/30/2015 | 3,008 | -631 | N/A | -177 | N/A |
3/31/2015 | 2,116 | -648 | N/A | -161 | N/A |
12/31/2014 | 1,223 | -665 | N/A | -145 | N/A |
9/30/2014 | 617 | -371 | N/A | -34 | N/A |
6/30/2014 | 11 | -76 | N/A | 77 | N/A |
3/31/2014 | 51 | -19 | N/A | 59 | N/A |
12/31/2013 | 90 | 37 | N/A | 41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1094's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 1094's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1094's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1094's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1094's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1094's Return on Equity is forecast to be high in 3 years time